Taken together, these results suggest that by evading β-TRCP-mediated degradation, cells expressing the non-degradable version of NEDD4 (NEDD4-AA) have increased cell growth and cell migration, presumably through the activated mTOR/Akt pathway by suppressing the PTEN tumor suppressor. Here, BTRC is linked to neoplasm.